BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

961 related articles for article (PubMed ID: 27338697)

  • 1. Selective depletion of CD11c
    Wang L; Li Z; Ciric B; Safavi F; Zhang GX; Rostami A
    Eur J Immunol; 2016 Oct; 46(10):2454-2466. PubMed ID: 27338697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD11c+CD11b+ dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis.
    Li H; Zhang GX; Chen Y; Xu H; Fitzgerald DC; Zhao Z; Rostami A
    J Immunol; 2008 Aug; 181(4):2483-93. PubMed ID: 18684939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune tolerance induced by intravenous transfer of immature dendritic cells via up-regulating numbers of suppressive IL-10(+) IFN-γ(+)-producing CD4(+) T cells.
    Zhou F; Ciric B; Zhang GX; Rostami A
    Immunol Res; 2013 May; 56(1):1-8. PubMed ID: 23292714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
    Mari ER; Rasouli J; Ciric B; Moore JN; Conejo-Garcia JR; Rajasagi N; Zhang GX; Rabinovich GA; Rostami A
    Eur J Immunol; 2016 Jul; 46(7):1783-96. PubMed ID: 27151444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-β regulates dendritic cell activation and migration in experimental autoimmune encephalomyelitis.
    Pennell LM; Fish EN
    Immunology; 2017 Nov; 152(3):439-450. PubMed ID: 28646573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b
    Arellano G; Acuña E; Loda E; Moore L; Tichauer JE; Castillo C; Vergara F; Burgos PI; Penaloza-MacMaster P; Miller SD; Naves R
    J Neuroinflammation; 2024 May; 21(1):144. PubMed ID: 38822334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis.
    Zhou F; Ciric B; Zhang GX; Rostami A
    Clin Exp Immunol; 2014 Dec; 178(3):447-58. PubMed ID: 25138204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of MS-like disease by a multi epitope protein is mediated by induction of CD11c
    Kaushansky N; Kaminitz A; Allouche-Arnon H; Ben-Nun A
    J Neuroimmunol; 2019 Aug; 333():476953. PubMed ID: 31108399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.
    Wang D; Ghosh D; Islam SM; Moorman CD; Thomason AE; Wilkinson DS; Mannie MD
    J Immunol; 2016 Oct; 197(8):2992-3007. PubMed ID: 27619998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis.
    Yuan B; Zhao L; Fu F; Liu Y; Lin C; Wu X; Shen H; Yang Z
    Mol Immunol; 2014 Feb; 57(2):93-9. PubMed ID: 24084097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
    Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
    J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4
    Zhou F; Zhang GX; Rostami A
    Immunol Res; 2017 Jun; 65(3):630-638. PubMed ID: 27942984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4
    Moorman CD; Bastian AG; DeOca KB; Mannie MD
    J Neuroinflammation; 2020 Jun; 17(1):180. PubMed ID: 32522287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL.
    Hirata S; Matsuyoshi H; Fukuma D; Kurisaki A; Uemura Y; Nishimura Y; Senju S
    J Immunol; 2007 Jan; 178(2):918-25. PubMed ID: 17202353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4
    Wan X; Pei W; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
    J Immunol; 2018 Aug; 201(4):1194-1210. PubMed ID: 29987163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental autoimmune encephalomyelitis (EAE) induced by antigen pulsed dendritic cells in the C57BL/6 mouse: influence of injection route.
    Aghdami N; Gharibdoost F; Moazzeni SM
    Exp Anim; 2008 Jan; 57(1):45-55. PubMed ID: 18256518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
    Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
    Front Immunol; 2018; 9():3119. PubMed ID: 30687323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
    Isaksson M; Lundgren BA; Ahlgren KM; Kämpe O; Lobell A
    Eur J Immunol; 2012 Oct; 42(10):2555-63. PubMed ID: 22806332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.